H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy
Acetylation and deacetylation are posttranslational modifications (PTMs) which affect the regulation of chromatin structure and its remodeling. Acetylation of histone 3 at lysine placed on position 18 (H3K18Ac) plays an important role in driving progression of many types of cancer, including breast,...
Main Authors: | Marta Hałasa, Anna Wawruszak, Alicja Przybyszewska, Anna Jaruga, Małgorzata Guz, Joanna Kałafut, Andrzej Stepulak, Marek Cybulski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/5/485 |
Similar Items
-
HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
by: Jie Wang, et al.
Published: (2022-12-01) -
Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy
by: Peng Ding, et al.
Published: (2022-05-01) -
HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape
by: Michela Gottardi Zamperla, et al.
Published: (2024-08-01) -
Histone acetylation and the role of histone deacetylases in normal cyclic endometrium
by: Palak Gujral, et al.
Published: (2020-08-01) -
Changes in histone lysine acetylation, but not DNA methylation during facultative hibernation in Syrian hamster liver
by: Marloes M. Oosterhof, et al.
Published: (2024-01-01)